PubMed:1457973 / 771-916 JSONTXT

{"project":"Glycan-Motif","denotations":[{"id":"T5","span":{"begin":84,"end":105},"obj":"https://glytoucan.org/Structures/Glycans/G27025MB"}],"text":"WFA has been shown to have affinity for oligosaccharides containing beta 1,4-linked N-acetylgalactosamine (GalNAc) at their non-reducing termini."}

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T5","span":{"begin":84,"end":105},"obj":"Glycan_Motif"}],"attributes":[{"id":"A5","pred":"image","subj":"T5","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G27025MB"}],"text":"WFA has been shown to have affinity for oligosaccharides containing beta 1,4-linked N-acetylgalactosamine (GalNAc) at their non-reducing termini."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T6","span":{"begin":0,"end":145},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":145},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":145},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"WFA has been shown to have affinity for oligosaccharides containing beta 1,4-linked N-acetylgalactosamine (GalNAc) at their non-reducing termini."}

{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T5","span":{"begin":84,"end":105},"obj":"https://glytoucan.org/Structures/Glycans/G27025MB"}],"text":"WFA has been shown to have affinity for oligosaccharides containing beta 1,4-linked N-acetylgalactosamine (GalNAc) at their non-reducing termini."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T24","span":{"begin":40,"end":56},"obj":"FMAID:82742"},{"id":"_T25","span":{"begin":40,"end":56},"obj":"FMAID:196731"},{"id":"_T26","span":{"begin":84,"end":105},"obj":"FMAID:82786"},{"id":"_T27","span":{"begin":84,"end":105},"obj":"FMAID:196780"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"WFA has been shown to have affinity for oligosaccharides containing beta 1,4-linked N-acetylgalactosamine (GalNAc) at their non-reducing termini."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T18","span":{"begin":68,"end":72},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/158455"},{"id":"T19","span":{"begin":68,"end":72},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/3554"},{"id":"T20","span":{"begin":124,"end":127},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/604139"}],"text":"WFA has been shown to have affinity for oligosaccharides containing beta 1,4-linked N-acetylgalactosamine (GalNAc) at their non-reducing termini."}

{"project":"Lectin","denotations":[{"id":"Lectin_T4","span":{"begin":0,"end":3},"obj":"https://acgg.asia/db/lfdb/LfDB0188"}],"text":"WFA has been shown to have affinity for oligosaccharides containing beta 1,4-linked N-acetylgalactosamine (GalNAc) at their non-reducing termini."}

{"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T1","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G23425WZ\""},{"id":"GlycanIUPAC_T4","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G02874VH\""},{"id":"GlycanIUPAC_T7","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G99699DW\""},{"id":"GlycanIUPAC_T10","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G22074RM\""},{"id":"GlycanIUPAC_T13","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G48535VZ\""},{"id":"GlycanIUPAC_T16","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G39738WL\""},{"id":"GlycanIUPAC_T19","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G42313WU\""},{"id":"GlycanIUPAC_T22","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G00393CK\""},{"id":"GlycanIUPAC_T25","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G42649EX\""},{"id":"GlycanIUPAC_T28","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G46880SB\""},{"id":"GlycanIUPAC_T31","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G75599IR\""},{"id":"GlycanIUPAC_T34","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G58985MU\""},{"id":"GlycanIUPAC_T37","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G92517PO\""},{"id":"GlycanIUPAC_T40","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G88512YL\""},{"id":"GlycanIUPAC_T43","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G41473NX\""},{"id":"GlycanIUPAC_T46","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G71089RB\""},{"id":"GlycanIUPAC_T49","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G73485GZ\""},{"id":"GlycanIUPAC_T52","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G61406KC\""},{"id":"GlycanIUPAC_T55","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G34412GZ\""},{"id":"GlycanIUPAC_T58","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G67209FP\""},{"id":"GlycanIUPAC_T61","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G61442IL\""},{"id":"GlycanIUPAC_T64","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G93729MV\""},{"id":"GlycanIUPAC_T67","span":{"begin":107,"end":113},"obj":"\"http://rdf.glycoinfo.org/glycan/G92144AE\""},{"id":"GlycanIUPAC_T70","span":{"begin":124,"end":127},"obj":"\"http://rdf.glycoinfo.org/glycan/G02780QX\""},{"id":"GlycanIUPAC_T71","span":{"begin":124,"end":127},"obj":"\"http://rdf.glycoinfo.org/glycan/G18425DX\""},{"id":"GlycanIUPAC_T72","span":{"begin":124,"end":127},"obj":"\"http://rdf.glycoinfo.org/glycan/G18630JE\""},{"id":"GlycanIUPAC_T73","span":{"begin":124,"end":127},"obj":"\"http://rdf.glycoinfo.org/glycan/G01004IT\""},{"id":"GlycanIUPAC_T74","span":{"begin":124,"end":127},"obj":"\"http://rdf.glycoinfo.org/glycan/G87301QZ\""},{"id":"GlycanIUPAC_T75","span":{"begin":124,"end":127},"obj":"\"http://rdf.glycoinfo.org/glycan/G39790GW\""},{"id":"GlycanIUPAC_T76","span":{"begin":124,"end":127},"obj":"\"http://rdf.glycoinfo.org/glycan/G42928BB\""},{"id":"GlycanIUPAC_T77","span":{"begin":124,"end":127},"obj":"\"http://rdf.glycoinfo.org/glycan/G51134HC\""},{"id":"GlycanIUPAC_T78","span":{"begin":124,"end":127},"obj":"\"http://rdf.glycoinfo.org/glycan/G68183GR\""},{"id":"GlycanIUPAC_T79","span":{"begin":124,"end":127},"obj":"\"http://rdf.glycoinfo.org/glycan/G46883FA\""},{"id":"GlycanIUPAC_T80","span":{"begin":124,"end":127},"obj":"\"http://rdf.glycoinfo.org/glycan/G54702VY\""}],"text":"WFA has been shown to have affinity for oligosaccharides containing beta 1,4-linked N-acetylgalactosamine (GalNAc) at their non-reducing termini."}

{"project":"Glycan-GlyCosmos","denotations":[{"id":"T1","span":{"begin":107,"end":113},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G39738WL"},{"id":"A5","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL"}],"text":"WFA has been shown to have affinity for oligosaccharides containing beta 1,4-linked N-acetylgalactosamine (GalNAc) at their non-reducing termini."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T6","span":{"begin":0,"end":145},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":145},"obj":"Sentence"},{"id":"T6","span":{"begin":0,"end":145},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"WFA has been shown to have affinity for oligosaccharides containing beta 1,4-linked N-acetylgalactosamine (GalNAc) at their non-reducing termini."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T6","span":{"begin":0,"end":145},"obj":"Sentence"}],"text":"WFA has been shown to have affinity for oligosaccharides containing beta 1,4-linked N-acetylgalactosamine (GalNAc) at their non-reducing termini."}

{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T1","span":{"begin":107,"end":113},"obj":"Glycan"}],"attributes":[{"id":"A1","pred":"glycosmos_id","subj":"T1","obj":"https://glycosmos.org/glycans/show/G39738WL"},{"id":"A5","pred":"image","subj":"T1","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL"}],"text":"WFA has been shown to have affinity for oligosaccharides containing beta 1,4-linked N-acetylgalactosamine (GalNAc) at their non-reducing termini."}